J. Newman

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer

N. Seetharamu, Chung-Shien Lee, Kevin Y Wang, 2021, SAGE open medicine.

Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors.

M. Saif, N. Seetharamu, J. Newman, 2020, Cancer medicine journal.

Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer

C. Devoe, I. Preeshagul, N. Kohn, 2020, Lung cancer management.

Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with De Novo Stage IV Breast Cancer

M. Egeblad, T. Fujii, H. Rehman, 2021, Journal of Cancer.